Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy (LD-NEPA).

Diseases · 2026 · PMC13407607 · PMID 42505559

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

A numerical trend toward reduced efficacy was observed in patients with the highest number of emetogenic risk factors; however, this finding was based on a small sample size and was associated with wide confidence intervals, indicating substantial uncertainty.

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.